FTC sues main pharmacy profit managers in excess of insulin costs The agency introduced action against Caremark, Specific Scripts and Optum Rx, arguing their “anticompetitive and unfair” rebating procedures “artificially inflated” the record price of everyday living-saving insulin medications. Listen to the article 10 min This audio is auto-generated. Please https://rowanluvci.fitnell.com/71432838/the-single-best-strategy-to-use-for-healthcare-news